Zagotenemab
Zagotenemab (LY3303560) is a humanised anti-tau antibody that selectively binds and neutralises tau deposits in the brain. Zagotenemab can be used in Alzheimer's disease research[1].
Product Specifications
CAS Number
[2019133-28-7]
Product Name Alternative
LY33003560
UNSPSC
12352203
Target
Microtubule/Tubulin
Type
Inhibitory Antibodies
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/zagotenemab.html
Purity
99.28
Solubility
10 mM in DMSO
Smiles
[Zagotenemab]
Molecular Weight
(145.3 kDa)
References & Citations
[1]Abyadeh M, et al. Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's Disease. Aging Dis. 2021 Dec 1;12 (8) :1964-1976.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
43088124 3x 1.0µg DNA
SCAMP5 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Ask
View Details 
F4150-13H 50 µg
FK506 Binding Protein 2, aa22-142, Recombinant, Human (FKBP2, FKBP-2, 13kD FK506-binding Protein, 13kD FKBP, FKBP13, FKBP-13, Immunophilin FKBP13, Peptidyl-prolyl Cis-trans Isomerase FKBP2, PPIase FKBP2, Rotamase)
Ask
View Details 
